• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why NetEase Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket

    11/17/22 7:49:40 AM ET
    $ARDX
    $BBWI
    $BNOX
    $BTB
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary
    Get the next $ARDX alert in real time by email

    Gainers

    • Ardelyx Inc (NASDAQ:ARDX) shares rose 81.2% to $2.21 in pre-market trading as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis.
    • Elevate Credit, Inc. (NYSE:ELVT) shares rose 65.1% to $1.75 in pre-market trading after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million.
    • Cuentas Inc. (NASDAQ:CUEN) rose 29.6% to $0.3239 in pre-market trading after dropping 28% on Wednesday. Cuentas authorized a share repurchase program.
    • Bath & Body Works, Inc. (NYSE:BBWI) rose 22.3% to $38.09 in pre-market trading after the company reported better-than-expected Q3 results and raised FY22 earnings forecast.
    • SomaLogic, Inc. (NASDAQ:SLGC) rose 14.5% to $3.08 in pre-market trading. The company recently posted upbeat Q3 results and raised FY22 revenue guidance.
    • The9 Limited (NASDAQ:NCTY) rose 10.8% to $0.9105 in pre-market trading. The9 is scheduled to hold its annual general meeting on December 19, 2022.
    • Companhia Energética de Minas Gerais (NYSE:CIG) shares jumped 10.3% to $2.14 in pre-market trading following a 3% decline in the previous session.
    • Cartesian Growth Corporation (NASDAQ:GLBL) rose 10.1% to $9.48 in pre-market trading after dropping over 15% on Wednesday.
    • Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) rose 9.8% to $0.67 in pre-market trading. BML Investment Partners LP reported a 19.4% passive stake in Satsuma Pharmaceuticals as of November 14.
    • Bit Brother Limited (NASDAQ:BTB) rose 9.1% to $0.1699 in pre-market trading after declining over 5% on Wednesday.
    • Skillz Inc. (NYSE:SKLZ) rose 7.5% to $1.15 in pre-market trading after dropping 10% on Wednesday.
    • Cisco Systems, Inc. (NASDAQ:CSCO) rose 4% to $46.16 in pre-market trading after the company reported better-than-expected Q1 results.

     

    Don’t forget to check out our premarket coverage here .


    Losers

    • Fast Radius, Inc. (NASDAQ:FSRD) shares fell 23.2% to $0.1613 in pre-market trading on continued volatility after the company recently established a timeline for a Chapter 11 sale process. The company’s stock jumped 106% on Wednesday.
    • Bionomics Limited (NASDAQ:BNOX) fell 15.1% to $7.20 in pre-market trading after the company reported pricing of underwritten offering of 641,026 American Depositary Shares in the U.S. at a price of $7.80 per ADS.
    • SenesTech, Inc. (NASDAQ:SNES) shares fell 13.5% to $2.81 in pre-market trading. SenesTech reported pricing of $5 million public offering.
    • Vaccitech plc (NASDAQ:VACC) fell 10% to $2.17 in pre-market trading. Vaccitech recently posted Q3 EPS of $0.22.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) shares fell 9.2% to $2.53 in pre-market trading after surging 29% on Wednesday.
    • Ormat Technologies, Inc. (NYSE:ORA) fell 8.9% to $91.25 in pre-market trading. Ormat reported pricing of upsized public offering of 3.75 million shares of common stock on behalf of stockholder ORIX Corporation at a price of $90 per share.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 8.9% to $0.1275 in pre-market trading after jumping around 12% on Wednesday.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) shares fell 8.2% to $1.12 in pre-market trading after dropping 9% on Wednesday.
    • Perfect Corp. (NYSE:PERF) fell 8% to $8.22 in pre-market trading after dipping 10% on Wednesday.
    • Sensus Healthcare, Inc. (NASDAQ:SRTS) fell 7.8% to $6.70 in pre-market trading after dropping 7% on Wednesday.
    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) fell 7.3% to $0.7730 in pre-market trading. Sunshine Biopharma recently entered into a collaboration agreement with a North American lipid nanoparticle (LNP) company to advance the development of its mRNA-based anticancer macromolecule, K1.1.
    • Flotek Industries, Inc. (NYSE:FTK) shares fell 6.6% to $0.99 in pre-market trading. Flotek Industries recently posted a Q3 loss of $0.25 per share.
    • NetEase, Inc. (NASDAQ:NTES) shares fell 5.6% to $67.35 in pre-market trading after the company reported weak quarterly sales.
    Get the next $ARDX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARDX
    $BBWI
    $BNOX
    $BTB

    CompanyDatePrice TargetRatingAnalyst
    Cisco Systems Inc.
    $CSCO
    2/18/2026Buy → Hold
    Erste Group
    Bath & Body Works Inc.
    $BBWI
    2/17/2026$25.00Buy → Neutral
    Citigroup
    Ormat Technologies Inc.
    $ORA
    2/13/2026$130.00Buy → Hold
    Jefferies
    Flotek Industries Inc.
    $FTK
    1/29/2026$25.00Buy
    Lake Street
    Cisco Systems Inc.
    $CSCO
    1/26/2026$100.00In-line → Outperform
    Evercore ISI
    Bath & Body Works Inc.
    $BBWI
    1/14/2026$24.00Hold
    Jefferies
    Ormat Technologies Inc.
    $ORA
    1/9/2026$130.00Hold → Buy
    TD Cowen
    Ardelyx Inc.
    $ARDX
    1/9/2026Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $ARDX
    $BBWI
    $BNOX
    $BTB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $56,667 worth of shares (31,346 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/13/26 5:20:17 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $15,480 worth of shares (8,569 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/6/26 5:40:20 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $ARDX
    $BBWI
    $BNOX
    $BTB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Operations Subaiya Thimaya K. sold $804,268 worth of shares (10,233 units at $78.60), decreasing direct ownership by 6% to 160,153 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    2/20/26 4:16:51 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form 3 filed by new insider Biscotti Larry Joseph

    3 - Sensus Healthcare, Inc. (0001494891) (Issuer)

    2/18/26 3:48:31 PM ET
    $SRTS
    Medical/Dental Instruments
    Health Care

    $ARDX
    $BBWI
    $BNOX
    $BTB
    SEC Filings

    View All

    SEC Form 144 filed by Ardelyx Inc.

    144 - ARDELYX, INC. (0001437402) (Subject)

    2/20/26 6:07:59 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Ardelyx Inc.

    144 - ARDELYX, INC. (0001437402) (Subject)

    2/20/26 5:33:56 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sunshine Biopharma Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Sunshine Biopharma Inc. (0001402328) (Filer)

    2/20/26 4:08:43 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARDX
    $BBWI
    $BNOX
    $BTB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cisco downgraded by Erste Group

    Erste Group downgraded Cisco from Buy to Hold

    2/18/26 9:41:39 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    Bath & Body Works downgraded by Citigroup with a new price target

    Citigroup downgraded Bath & Body Works from Buy to Neutral and set a new price target of $25.00

    2/17/26 8:12:52 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Ormat Tech downgraded by Jefferies with a new price target

    Jefferies downgraded Ormat Tech from Buy to Hold and set a new price target of $130.00

    2/13/26 8:36:01 AM ET
    $ORA
    Electric Utilities: Central
    Utilities

    $ARDX
    $BBWI
    $BNOX
    $BTB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARDX
    $BBWI
    $BNOX
    $BTB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sharon AI & Cisco Launch Australia's First Cisco Secure AI Factory with NVIDIA

    News summary Cisco and Sharon AI launch Australia's first Cisco Secure AI Factory with NVIDIA, providing secure, high-performance AI infrastructure with all data processing remaining in the country. Powered by 1024 NVIDIA Blackwell Ultra GPUs, Cisco's UCS servers and Nexus Hyperfabric technology, it supports Australia's National AI Plan and accelerates enterprise AI adoption and innovation across the Asia-Pacific region. This initiative positions Australia to lead in sovereign and responsible AI, empowering enterprises to develop advanced AI solutions while maintaining the highest security standards. Today, Cisco (NASDAQ:CSCO) and SharonAI Holdings Inc. (NASDAQ:SHAZ) and its sub

    2/23/26 12:15:00 AM ET
    $CSCO
    $SHAZ
    Computer Communications Equipment
    Telecommunications
    EDP Services
    Technology

    Bath & Body Works Officially Launches in Amazon's U.S. Stores, Expanding Access to Its Iconic Fragrances and Most Loved Products

    COLUMBUS, Ohio, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works today announced its official launch in Amazon's U.S. stores, making it easier than ever for consumers to discover and shop the brand's iconic fragrances and most loved products. Beginning today, consumers in the U.S. can explore a curated selection of Bath & Body Works' iconic body care and home fragrances—including best sellers like Champagne Toast, A Thousand Wishes, Mahogany Teakwood, and Eucalyptus Spearmint—available in a wide range of fan-favorite forms such as fine fragrance mists, body wash, body cream, hand soap, 3-wick and single wick candles, Wallflowers, and more. This launch establishes the first authorized

    2/20/26 9:00:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    IBSRELA revenue grew 73% in 2025 to $274.2 million and total revenues reached $407.3 million Patient-first XPHOZAH strategy preserved access and drove growth in total dispenses Development programs for new IBSRELA indication and next-generation NHE3 inhibitor launched Company is well capitalized to meet current business objectives Conference call scheduled for 4:30 PM Eastern Time WALTHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today reported financial results for the fourth quarter and full year

    2/19/26 4:01:00 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARDX
    $BBWI
    $BNOX
    $BTB
    Leadership Updates

    Live Leadership Updates

    View All

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Sensus Healthcare Appoints Larry Biscotti to its Board of Directors

    Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the appointment of Larry Biscotti to its Board of Directors, effective immediately. With this appointment the Sensus Healthcare Board has six Directors, including four independent Directors. Mr. Biscotti brings more than 25 years of executive leadership experience in the medical device and healthcare technology sectors, with an extensive background in driving commercial strategy, expanding global market share and launching advanced imaging and oncology technologi

    1/7/26 8:30:00 AM ET
    $SRTS
    Medical/Dental Instruments
    Health Care

    Bath & Body Works Outlines Strategic Transformation for Sustainable Growth and Reports 2025 Third Quarter Results

    Launches the Consumer First Formula with four strategic priorities to drive sustainable long-term growthThird-quarter net sales of $1.6 billion, down 1%. Earnings per diluted share of $0.37; Adjusted earnings per diluted share of $0.35Q4 and full-year 2025 guidance lowered reflecting current business trends and continuation of recent macro consumer pressures COLUMBUS, Ohio, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE:BBWI) today reported third quarter 2025 results. Daniel Heaf, chief executive officer of Bath & Body Works, commented, "Today, we are excited to announce a comprehensive transformation plan to revitalize Bath & Body Works across brand, product, and market

    11/20/25 6:55:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ARDX
    $BBWI
    $BNOX
    $BTB
    Financials

    Live finance-specific insights

    View All

    Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    IBSRELA revenue grew 73% in 2025 to $274.2 million and total revenues reached $407.3 million Patient-first XPHOZAH strategy preserved access and drove growth in total dispenses Development programs for new IBSRELA indication and next-generation NHE3 inhibitor launched Company is well capitalized to meet current business objectives Conference call scheduled for 4:30 PM Eastern Time WALTHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today reported financial results for the fourth quarter and full year

    2/19/26 4:01:00 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bath & Body Works to Report Fourth Quarter and Fiscal 2025 Results on March 4, 2026

    COLUMBUS, Ohio, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE:BBWI) announced today that it plans to report its fourth quarter and fiscal 2025 financial results before market open on Wednesday, March 4, 2026. In conjunction with this report, the company will host a conference call at 8:30 a.m. ET during which Daniel Heaf, chief executive officer, and Eva Boratto, chief financial officer, will discuss the company's results and provide a business update. Supplemental materials will be posted approximately 90 minutes prior to the start of the conference call on the events and presentations page in the Investors section of the company's website at bbwinc.com. Investors and a

    2/18/26 8:30:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer

    2026 CMS Physician Fee Schedule Final Rule provides a 300% per-fraction increase to delivery code that became effective January 1, 2026 Company enters 2026 with reimbursement certainty and strategic visibility, expects sequential-quarter revenue growth in Q1 and full-year profitability Shipped 14 SRT systems in Q4, most in December and none to its historically largest customer, up from six systems in Q3 excluding shipments to its historically largest customer Conference call begins at 4:30 p.m. Eastern time today Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for onc

    2/12/26 4:05:00 PM ET
    $SRTS
    Medical/Dental Instruments
    Health Care

    $ARDX
    $BBWI
    $BNOX
    $BTB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Ormat Technologies Inc.

    SC 13D/A - ORMAT TECHNOLOGIES, INC. (0001296445) (Subject)

    12/13/24 4:05:21 PM ET
    $ORA
    Electric Utilities: Central
    Utilities

    Amendment: SEC Form SC 13D/A filed by Skillz Inc.

    SC 13D/A - Skillz Inc. (0001801661) (Subject)

    12/12/24 4:01:36 PM ET
    $SKLZ
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:28:08 PM ET
    $SNES
    Agricultural Chemicals
    Industrials